Pillar Pharmaceuticals 6 L.P. 13D and 13G filings for Idera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-05 4:35 pm Unchanged |
2022-09-27 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
0 (Unchanged) |
Filing |
| 2022-06-30 5:58 pm Unchanged |
2022-06-30 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
0 (Unchanged) |
Filing |
| 2022-06-24 4:54 pm Unchanged |
2022-06-09 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
0 (Unchanged) |
Filing |
| 2021-06-07 5:25 pm Sale |
2021-06-01 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,015,836 19.900% |
-188 (-0.01%) |
Filing |
| 2021-03-31 9:02 pm Sale |
2021-03-18 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,016,025 19.900% |
-202,026 (-9.11%) |
Filing |
| 2020-12-30 09:16 am Purchase |
2020-12-11 | 13D | Idera Pharmaceuticals, Inc. IDRA |
Pillar Pharmaceuticals 6 L.P. | 2,218,050 19.900% |
2,218,050 (New Position) |
Filing |